Zhangzhou Pientzehuang Pharmaceutical., Ltd (600436.SS)
CNY 220.76
(0.79%)
CNY 220.76
(0.79%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.33 Billion CNY | 20.18% |
| 2022 | 1.1 Billion CNY | 25.28% |
| 2021 | 885.21 Million CNY | 23.22% |
| 2020 | 718.38 Million CNY | 3.09% |
| 2019 | 696.84 Million CNY | 16.22% |
| 2018 | 599.59 Million CNY | 28.42% |
| 2017 | 466.9 Million CNY | -28.25% |
| 2016 | 650.72 Million CNY | 83.05% |
| 2015 | 355.49 Million CNY | 19.07% |
| 2014 | 298.57 Million CNY | -14.84% |
| 2013 | 350.58 Million CNY | -3.23% |
| 2012 | 362.28 Million CNY | 154.12% |
| 2011 | 142.56 Million CNY | 21.29% |
| 2010 | 117.54 Million CNY | -49.47% |
| 2009 | 232.6 Million CNY | 36.83% |
| 2008 | 170 Million CNY | 136.11% |
| 2007 | 72 Million CNY | 1700.0% |
| 2006 | 4 Million CNY | -55.56% |
| 2005 | 9 Million CNY | 0.0% |
| 2004 | - CNY | 0.0% |
| 2003 | - CNY | -100.0% |
| 2002 | 30 Million CNY | -14.29% |
| 2001 | 35 Million CNY | 250.0% |
| 2000 | 10 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 1.46 Billion CNY | 10.29% |
| 2024 Q2 | 1.23 Billion CNY | -15.84% |
| 2024 Q3 | 1.03 Billion CNY | -7.39% |
| 2023 FY | 1.33 Billion CNY | 20.18% |
| 2023 Q3 | 968.5 Million CNY | -6.92% |
| 2023 Q4 | 1.33 Billion CNY | 37.61% |
| 2023 Q1 | 1.03 Billion CNY | -6.47% |
| 2023 Q2 | 1.04 Billion CNY | 0.32% |
| 2022 Q3 | 932.88 Million CNY | 1.22% |
| 2022 Q4 | 1.1 Billion CNY | 18.88% |
| 2022 FY | 1.1 Billion CNY | 25.28% |
| 2022 Q1 | 819.53 Million CNY | -7.42% |
| 2022 Q2 | 921.66 Million CNY | 12.46% |
| 2021 Q2 | 805.79 Million CNY | 2.67% |
| 2021 Q1 | 784.8 Million CNY | 9.25% |
| 2021 FY | 885.21 Million CNY | 23.22% |
| 2021 Q4 | 885.21 Million CNY | 10.14% |
| 2021 Q3 | 803.75 Million CNY | -0.25% |
| 2020 Q1 | 736.81 Million CNY | 5.74% |
| 2020 FY | 718.38 Million CNY | 3.09% |
| 2020 Q2 | 663.53 Million CNY | -9.94% |
| 2020 Q4 | 718.38 Million CNY | 1.68% |
| 2020 Q3 | 706.5 Million CNY | 6.48% |
| 2019 Q1 | 694.6 Million CNY | 15.85% |
| 2019 Q3 | 795 Million CNY | 8.96% |
| 2019 Q4 | 696.84 Million CNY | -12.35% |
| 2019 FY | 696.84 Million CNY | 16.22% |
| 2019 Q2 | 729.6 Million CNY | 5.04% |
| 2018 Q4 | 599.59 Million CNY | -3.76% |
| 2018 Q3 | 623 Million CNY | 9.9% |
| 2018 Q2 | 566.9 Million CNY | 8.62% |
| 2018 Q1 | 521.9 Million CNY | 11.78% |
| 2018 FY | 599.59 Million CNY | 28.42% |
| 2017 Q4 | 466.9 Million CNY | -2.24% |
| 2017 Q2 | 375 Million CNY | 2.47% |
| 2017 Q1 | 365.96 Million CNY | -43.76% |
| 2017 FY | 466.9 Million CNY | -28.25% |
| 2017 Q3 | 477.59 Million CNY | 27.36% |
| 2016 Q4 | 650.72 Million CNY | 14.04% |
| 2016 Q3 | 570.59 Million CNY | 23.38% |
| 2016 FY | 650.72 Million CNY | 83.05% |
| 2016 Q2 | 462.48 Million CNY | 10.82% |
| 2016 Q1 | 417.31 Million CNY | 17.39% |
| 2015 Q1 | 298.72 Million CNY | 0.05% |
| 2015 FY | 355.49 Million CNY | 19.07% |
| 2015 Q2 | 298.86 Million CNY | 0.05% |
| 2015 Q4 | 355.49 Million CNY | 15.03% |
| 2015 Q3 | 309.04 Million CNY | 3.4% |
| 2014 Q2 | 306.97 Million CNY | -2.7% |
| 2014 FY | 298.57 Million CNY | -14.84% |
| 2014 Q1 | 315.47 Million CNY | -10.01% |
| 2014 Q4 | 298.57 Million CNY | -2.78% |
| 2014 Q3 | 307.12 Million CNY | 0.05% |
| 2013 Q1 | 351.28 Million CNY | -3.04% |
| 2013 Q2 | 357.79 Million CNY | 1.85% |
| 2013 Q3 | 351.56 Million CNY | -1.74% |
| 2013 FY | 350.58 Million CNY | -3.23% |
| 2013 Q4 | 350.58 Million CNY | -0.28% |
| 2012 FY | 362.28 Million CNY | 154.12% |
| 2012 Q3 | 378.7 Million CNY | 4.02% |
| 2012 Q2 | 364.06 Million CNY | -14.34% |
| 2012 Q1 | 425 Million CNY | 198.1% |
| 2012 Q4 | 362.28 Million CNY | -4.33% |
| 2011 FY | 142.56 Million CNY | 21.29% |
| 2011 Q4 | 142.56 Million CNY | -0.74% |
| 2011 Q1 | 132.37 Million CNY | 12.62% |
| 2011 Q2 | 166.39 Million CNY | 25.69% |
| 2011 Q3 | 143.63 Million CNY | -13.68% |
| 2010 Q3 | 166.65 Million CNY | -13.83% |
| 2010 FY | 117.54 Million CNY | -49.47% |
| 2010 Q4 | 117.54 Million CNY | -29.47% |
| 2010 Q1 | 211.85 Million CNY | -8.92% |
| 2010 Q2 | 193.39 Million CNY | -8.71% |
| 2009 FY | 232.6 Million CNY | 36.83% |
| 2009 Q1 | 170 Million CNY | 0.0% |
| 2009 Q2 | 215.06 Million CNY | 26.51% |
| 2009 Q3 | 161.39 Million CNY | -24.96% |
| 2009 Q4 | 232.6 Million CNY | 44.12% |
| 2008 FY | 170 Million CNY | 136.11% |
| 2008 Q1 | 61 Million CNY | -15.28% |
| 2008 Q2 | 48 Million CNY | -21.31% |
| 2008 Q4 | 170 Million CNY | 13.33% |
| 2008 Q3 | 150 Million CNY | 212.5% |
| 2007 Q4 | 72 Million CNY | 35.85% |
| 2007 Q3 | 53 Million CNY | -11.67% |
| 2007 Q2 | 60 Million CNY | 500.0% |
| 2007 Q1 | 10 Million CNY | 150.0% |
| 2007 FY | 72 Million CNY | 1700.0% |
| 2006 Q2 | 6 Million CNY | -33.33% |
| 2006 Q3 | 10.37 Million CNY | 72.85% |
| 2006 Q4 | 4 Million CNY | -61.43% |
| 2006 FY | 4 Million CNY | -55.56% |
| 2006 Q1 | 9 Million CNY | 0.0% |
| 2005 Q3 | 5 Million CNY | 0.0% |
| 2005 Q2 | - CNY | 0.0% |
| 2005 Q1 | - CNY | 0.0% |
| 2005 FY | 9 Million CNY | 0.0% |
| 2005 Q4 | 9 Million CNY | 80.0% |
| 2004 Q3 | - CNY | -100.0% |
| 2004 Q1 | - CNY | 0.0% |
| 2004 Q2 | 400 Thousand CNY | 0.0% |
| 2004 FY | - CNY | 0.0% |
| 2004 Q4 | - CNY | 0.0% |
| 2003 Q3 | - CNY | -100.0% |
| 2003 Q2 | 2.32 Million CNY | 0.0% |
| 2003 FY | - CNY | -100.0% |
| 2003 Q4 | - CNY | 0.0% |
| 2002 Q4 | 30 Million CNY | 0.0% |
| 2002 FY | 30 Million CNY | -14.29% |
| 2001 FY | 35 Million CNY | 250.0% |
| 2000 FY | 10 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 75.17 Million CNY | -1672.893% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 1.03 Billion CNY | -28.637% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 405.85 Million CNY | -228.396% |
| Aurora Optoelectronics Co.,Ltd. | 29.86 Million CNY | -4362.139% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 114.76 Million CNY | -1061.313% |
| NanJing Pharmaceutical Company Limited | 11.61 Billion CNY | 88.527% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 291.35 Million CNY | -357.44% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 150 Million CNY | -788.532% |